The Corden PharmaChem group was established following the acquisition of two manufacturing facilities in Cork, Ireland & Landen, Belgium by the International Chemical Investors Group (ICIG). Our sales & marketing function is based in Mannheim/ Plankstadt, Germany.

We provide products and services to accelerate the development and commercialization of branded and generic small molecule therapeutics. We support our customers worldwide with R&D and cGMP manufacturing facilities in Europe, an excellent regulatory compliance record and expertise in various chemical technologies.

We have extensive experience developing drug substances from early stage through clinical development, up to launch and commercial supply – from grams to tons. We provide a range of services, which include: route selection, process development, analytical development, process scale-up, safety assessments and optimization. Our core technologies and offerings include e.g. Hydrogenation, Biocatalysis/Biotransformation, Chiral Synthesis, Controlled Substances.